Use of tissue Doppler imaging to identify and manage systemic diseases

Clinical Research in Cardiology

Volumn 97, Issue 2, 2008, Pages 65-73

  Weidemann, Frank ^a   Strotmann, Joerg M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Myocardial function; Systemic disease; Velocity imaging

Indexed keywords

AMYLOIDOSIS; ANALYTICAL PARAMETERS; AUTOSOMAL DOMINANT INHERITANCE; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENZYME REPLACEMENT; FABRY DISEASE; FRIEDREICH ATAXIA; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART VENTRICLE WALL; HUMAN; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; PERICARDIAL EFFUSION; REVIEW; SARCOIDOSIS; SENSITIVITY ANALYSIS; SYSTEMIC DISEASE; TECHNIQUE; TISSUE DOPPLER IMAGING;

AMYLOIDOSIS; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY, DOPPLER; FABRY DISEASE; FEMALE; FRIEDREICH ATAXIA; GERMANY; HUMANS; MALE; MUSCULAR DYSTROPHIES; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 39149093990     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-007-0566-0     Document Type: Review

References (47)

1. Agretto A, Politano L, Bossone E, Petretta VR, D'Isa S, Passamano L, Comi LI, Erbel R (2002) Pulsed Doppler tissue imaging in dystrophinopathic cardiomyopathy. J Am Soc Echocardiogr 15:891-899
2. Bargout R, Kelly RF (2004) Sarcoid heart disease: clinical course and treatment. Int J Cardiol 97:173-182
3. Beer M, Weidemann F, Breunig F, Knoll A, Koeppe S, Machann W, Hahn D, Wanner C, Strotmann J, Sandstede J (2006) Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol 97:1515-1518
4. Bogaert J, Rademakers FE (2001) Regional nonuniformity of normal adult human left ventricle. Am J Physiol Heart Circ Physiol 280:H610-620
5. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH (2000) Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9:275-282
6. Bruch C, Schmermund A, Leischik R, Wallbridge D, Zamorano J, Erbel R (1997) Detection of ventricular asynchrony using tissue Doppler echocardiography - a new method for assessing left ventricular wall motion. Z Kardiol 86:827-838
7. Buyse G, Mertens L, Di Salvo G, Matthijs I, Weidemann F, Eyskens B, Goossens W, Goemans N, Sutherland GR, Van Hove JL (2003) Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60:1679-1681
8. Cheng AS, Banning AP, Mitchell AR, Neubauer S, Selvanayagam JB (2006) Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. Int J Cardiol 113:E21-23
9. Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7:1370-1378
10. Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, Offord KP, Greipp PR, Edwards WD, Tajik AJ (1985) Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6:737-743
11. Dubrey SW, Cha K, Skinner M, La- Valley M, Falk RH (1997) Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 78:74-82
12. Dutka DP, Donnelly JE, Palka P, Lange A, Nunez DJ, Nihoyannopoulos P (2000) Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation 102:1276-1282
13. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A - replacement therapy in Fabry's disease. N Engl J Med 345:9-16
14. Fung KC, Corbett A, Kritharides L (2003) Myocardial tissue velocity reduction is correlated with clinical neurologic severity in myotonic dystrophy. Am J Cardiol 92:177-181
15. Garot J, Derumeaux GA, Monin JL, Duval-Moulin AM, Simon M, Pascal D, Castaigne A, Dubois-Rande JL, Diebold B, Gueret P (1999) Quantitative systolic and diastolic transmyocardial velocity gradients assessed by M-mode colour Doppler tissue imaging as reliable indicators of regional left ventricular function after acute myocardial infarction. Eur Heart J 20:593-603
16. Hewer R (1969) The heart in Friedreich's ataxia. Br Heart J 31:5-14
17. Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M (2002) Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol 40:1668-1674
18. Kampmann C, Baehner FA, Whybra C, Bajbouj M, Baron K, Knuf M, Wiethoff CM, Trubel H, Beck M (2005) The right ventricle in Fabry disease. Acta Paediatr (Suppl 94):15-18; discussion 19-20
19. Koyama J, Davidoff R, Falk RH (2004) Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr 17:36-44
20. Koyama J, Ray-Sequin PA, Davidoff R, Falk RH (2002) Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 89:1067-1071
21. Koyama J, Ray-Sequin PA, Falk RH (2002) Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation 106:556-561
22. Kusachi S, Nishiyama O, Yasuhara K, Saito D, Haraoka S, Nagashima H (1982) Right and left ventricular oxygen metabolism in open-chest dogs. Am J Physiol 243:H761-766
23. Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665-683
24. Lindqvist P, Olofsson BO, Backman C, Suhr O, Waldenstrom A (2006) Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 7:22-30
25. Lunze FI, Hui W, Abd El Rahman MY, Alexi-Meskishvili V, Hetzer R, Lange PE, Berger F, Abdul-Khaliq H (2007) Preserved regional atrial contractile function following extra-atrial rather than intra-atrial type Fontan operation: a tissue Doppler imaging study. Clin Res Cardiol 96:264-271
26. Matsumori A, Hara M, Nagai S, Izumi T, Ohashi N, Ono K, Sasayama S (2000) Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 64:679-683
27. Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236-242
28. Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151-2155
29. Niedeggen A, Breithardt OA, Franke A (2005) Detection of early systolic dysfunction with strain rate imaging in a patient with light chain cardiomyopathy. Z Kardiol 94:133-136
30. Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk RH (2005) Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol 95:538-540
31. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Dopplercatheterization study. Circulation 102: 1788-1794
32. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A (2003) Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107:1978-1984
33. Poulsen SH, Sogaard P, Nielsen- Kudsk JE, Egeblad H (2003) Dilated cardiomyopathy in Friedreich's ataxia: 2D echo and tissue-Doppler analysis of left ventricular and atrial function. Eur J Echocardiogr 4:331-333
34. Rustin P, von Kleist-Retzow JC, Chantrel- Groussard K, Sidi D, Munnich A, Rotig A (1999) Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354:477-479
35. Sallach JA, Klein AL (2004) Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol 19:464-471
36. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M (1996) Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 10:495-510
37. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ (2005) Evaluation of the accuracy of gadolinium- enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683-1690
38. Smith GC, Kinali M, Prasad SK, Bonne G, Muntoni F, Pennell DJ, Nihoyannopoulos P (2006) Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8:723-730
39. Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J 3rd (2006) Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 113:960-968
40. Sutherland GR, Stewart MJ, Groundstroem KW, Moran CM, Fleming A, Guell-Peris FJ, Riemersma RA, Fenn LN, Fox KA, McDicken WN (1994) Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 7:441-458
41. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA (2000) Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102:1158-1164
42. Voigt JU, Flachskampf FA (2004) Strain and strain rate. New and clinically relevant echo parameters of regional myocardial function. Z Kardiol 93:249-258
43. Weidemann F, Breunig F, Beer M, Sandstede J, Stork S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2005) The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 26:1221-1227
44. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299- 1301
45. Weidemann F, Eyskens B, Mertens L, Di Salvo G, Strotmann J, Buyse G, Claus P, D'Hooge J, Bijnens B, Gewillig M, Sutherland GR (2003) Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes in Friedreich's ataxia. Am J Cardiol 91:622-626
46. Weidemann F, Jamal F, Sutherland GR, Claus P, Kowalski M, Hatle L, De Scheerder I, Bijnens B, Rademakers FE (2002) Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am J Physiol Heart Circ Physiol 283:H792-799
47. Yasutake H, Seino Y, Kashiwagi M, Honma H, Matsuzaki T, Takano T (2005) Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int J Cardiol 102:259-268